MBMikhail Yu. Brovko

Mikhail Yu. Brovko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikhail Yu. Brovko has a total of 160 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Export of Russian medical education: challenges and prospects

    by M. Yu. Brovko, M. S. Taratkin, P. P. Potapov, K. S. Voronin, V. I. Sholomova, T. A. Tatarinova

    Global competition for human recourses significantly increases the importance of education exports, including for Russia. The national development goals include increasing the number of foreign students up to 500,000 by 2030. Aim. To analyze the dynamics of the number of foreign medical students at Russian universities, with a perspective up to 2030, and to provide proposals for approaches to increasing the number of foreign students. Materials and methods. Data on the admission, number and graduation of foreign medical students were obtained from the federal statistical form “Information on the organization carrying out educational activities in higher education programs” posted on the website of the Ministry of Science and Higher Education of Russia. Statistical processing methods were used to analyze the data; forecasts were obtained using simple exponential smoothing methods. Results. The total number of students in medical specialties in 2024 showed an increase, amounting to 79,709 and 6740 people for extra-budgetary and budgetary forms of education funding, which corresponded to 24 % and 14 % of foreigners in all areas of training. Taking into account current admission rates and the average length of study in medical specialties, the estimated number of international students in medical programs may reach 140–142 thousand people by 2030 (excluding quota students). This indicator can be significantly influenced by the number of students who are expelled during their studies (up to 33 % in some specialties), which requires definite attention. Conclusion. Foreign citizens are interested in medical education in Russia, but to ensure sustainable growth during the period from 2025 to 2030, it is necessary to implement a comprehensive strategy aimed at increasing the attractiveness and competitiveness of Russian medical education, as well as creating favorable conditions for foreign students.


  • Open Access

    Prevalence and structure of sleep disorders in neurological, psychiatric and somatic hospitals

    by Dmitry S. Petelin, Andrey O. Golovatyuk, Beatrice A. Volel, Mikhail Yu. Brovko, Olga Yu. Sorokina, Daria V. Troshina, Dmitri O. Rozhkov, Nikolay M. Bulanov, Paraskovya S. Sokolova, Mikhail G. Poluektov, et al.

    Background. Today it is well known that the structure of sleep disorders and frequency of complaints about sleep disorders depend on the diseases profile. Emotional and behavioral features of patients with different disease profile are important factors affecting the development of sleep disorders. Aim. To estimate difference of sleep disorders according to the profile of the disease and to assess the emotional and psychological factors that may influence sleep disorders. Materials and methods. A total of 300 patients participated in the study: 100 from every department (neurological, psychiatric and pulmonological). To assess the quality of sleep Pittsburgh Sleep Quality Index was used; data from the Spielberger anxiety scale, a 5-factor personality questionnaire, and a questionnaire for evaluating coping strategies (coping strategies) were used to assess personal and emotional factors. Results. Patients from the psychotherapeutic group appeared to be more likely to complain of sleep disorders in general. They also had an average Pittsburgh Sleep Quality Index score higher than patients from neurological and somatic hospitals. In the group of patients with a neurological profile loud snoring is more often reason for sleep disturbing. Awakenings due to difficulties in breathing were more often detected in the group of somatic profile. Situational and personal anxiety influenced the structure of sleep disorders regardless of the disease profile. Conclusion. The use of various coping strategies has the greatest impact on the presence of sleep disorders in the group of patients with a somatic profile, to a lesser extent – in the group of neurological profile.

  • Open Access

    Basic aspects of meta-analysis. Part 2

    by E. A. Tao, M. Yu. Nadinskaia, A. Yu. Suvorov, N. M. Bulanov, V. I. Sholomova, P. P. Potapov, M. S. Taratkin, M. Yu. Brovko

    Meta-analysis combines the results of several scientific studies to obtain a summary quantitative estimation of effect size in order to compare the results of several studies and to identify patterns among them and possible sources of biases. Since the research teams, patients, research protocol, clinical guidelines and time intervals are often different between original scientific studies all these sources of difference can influence the results of each study, causing statistical heterogeneity. Meta-analyses are the highest level of credibility within evidence-based medicine, as they allow us to take into account the influence of many confounding factors and publication biases on the true effect size. Understanding the possible sources of erroneous conclusions in papers will allow researchers to analyze the results of such studies correctly and properly plan their own experiments. In this article the reader will be introduced to methods for identifying and quantifying hidden heterogeneity, such as subgroup analysis and meta-regression. In addition, the reader will learn how to calculate effect size in studies, estimate publication bias mathematically and graphically, and incorporate this estimate into the overall average effect size estimate in meta-analyses.


  • COVID-19 in medical workers: social demographic and clinical features in the examination of the correlation between the disease and an occupation

    by L.A. Strizhakov, R.E. Marchenkov, V.I. Sholomova, M.V. Lebedeva, M.YU. Brovko, D.V. Konovalov, S.V. Gulyaev

    Objective. To study social demographic indicators and risk factors of severe COVID-19 course, diagnosed in doctor’s, nursing and paramedical staff, as well as in health care workers not related to medical activities. Material and methods. The documentation of 83 medical and non-medical workers with a diagnosis of a novel coronovirus infection (COVID-19), who underwent the examination of correlation between disease and occupation in the center of occupational pathology on the basis of University Clinical Hospital No. 3 of the Sechenov First Moscow State Medical University (Sechenov University). Results. The data on the gender, age and social demographic distribution of medical and non-medical workers were obtained based on the results of examination analysis. The comorbid diseases in the whole sample and in the patients of separate groups were analyzed. Medical workers met with a very high occupational risk of disease during the COVID-19 pandemic. Doctors of different occupational groups often experienced a severe disease course and an adverse outcome when they were infected by COVID-19. The infection of medical workers is related to departments’ overcrowding, long-term contact with patients, lack of isolation rooms (spaces, areas) and high virus concentrations in the workplace. A necessary condition of individual protective equipment (IPE) effectiveness to reduce the risk of COVID-19 infection is the correct use of them, in particular, the choice of the optimal algorithm of IPE putting on and removing. Conclusion. The obtained results indicate a high risk of medical staff infection in the workplace with severe COVID-19 development. It is necessary to take into account risk factors that are predisposed to the development of a severe form of the disease, when determining medical contraindications for health care workers to work with infectious agents of the second category of pathogenicity. There are no significant differences in the structure of comorbid pathology, depending on whether the disease is recognized as occupational or not, in the sample of examined patients. This means that there is a necessity to make appropriate changes in occupational health regulations.


  • Prevalence and risk factors of delirium in COVID-19

    by Yu.G. Tikhonova, M.A. Kinkulkina, A.V. Volkov, V.A. Sedelkova, T.I. Avdeeva, T.A. Izyumina, M.A. Makarova, T.N. Maximova, M.YU. Brovko, S.V. Moiseev, et al.

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка распространенности и факторов риска развития делирия у госпитализированных пациентов с новой коронавирусной инфекцией (COVID-19). МАТЕРИАЛ И МЕТОДЫ Обследованы 440 пациентов, поступивших в инфекционный госпиталь Университетской клинической больницы №3 Сеченовского Университета с COVID-19. Использовались психометрические шкалы: опросник здоровья пациента (PHQ-9), скрининговый опросник генерализованного тревожного расстройства-7 (GAD-7), шкала оценки тяжести бессонницы (ISI), шкала оценки тяжести делирия (DRS-R-98). РЕЗУЛЬТАТЫ Делирий выявлен у 27,8% больных. Значимыми факторами риска являлись возраст (p=0,002), тяжесть дыхательной недостаточности (p=0,005), наличие сопутствующей соматической патологии (p=0,003), проведение респираторной терапии (ppp=0,07), наблюдаемых при поступлении, с риском развития делирия в течение срока госпитализации. ЗАКЛЮЧЕНИЕ Обнаружена высокая распространенность развивающегося при COVID-19 делирия. Для его предотвращения и/или снижения риска развития особое значение приобретают ранняя диагностика и выявление доклинических форм.

  • Open Access

    Interstitial pneumonia with autoimmune features: monocentric prospective study

    by L A Akulkina, A A Shchepalina, A S Moiseev, M Y Brovko, V I Sholomova, S V Moiseev

    Aim. To study demographic, clinical, serological and morphological features of interstitial pneumonia with autoimmune features (IPAF), compare survival in IPAF and interstitial lung disease in connective tissue diseases (CTD-ILD), and identify predictors of mortality and transformation to CTD in the IPAF group. Materials and methods. The IPAF group included 48 patients (75.0% women, median age 57.5 years), CTD-ILD 49 patients (79.6% women, median age 60.0 years). The analysis of demographic, clinical, laboratory and instrumental data was performed, as well as comparison of survival with the KaplanMeier method and the log-rank test in the IPAF and CTD-ILD groups. In the IPAF group, predictors of mortality and the development of CTD were studied with multivariate regression analysis. Results. Duration of observation period did not differ significantly in the IPAF and CTD-ILD groups (40.0 and 37.0 months, respectively). Clinical criteria of IPAF were observed in 25 (52.1%) patients, serological in 44 (91.7%), morphological in 44 (91.7%). Mortality in the IPAF group was significantly higher than in the CTD-ILD group (29.2 and 6.1%, respectively; p=0.023). The presence of diabetes mellitus, CT-pattern of usual interstitial pneumonia, and an initial low forced vital capacity value were independent predictors of mortality in the IPAF group. During the observation period, the development of CTD was noted in 4 (8.3%) patients with IPAF. The independent predictor of the CTD development was the increased C-reactive protein level. Conclusion. IPAF is characterized by a lower survival rate compared to CTD-ILD, and a relatively low risk of CTD transformation.


  • Open Access

    Acute Kidney Injury in Hospitalized Patients with COVID-19: Risk Factors and Serum Biomarkers

    by Anastasia Shchepalina, Natalia Chebotareva, Larissa Akulkina, Mikhail Brovko, Viktoria Sholomova, Tatiana Androsova, Yulia Korotchaeva, Diana Kalmykova, Elena Tanaschuk, Marina Taranova, et al.

    Background. AKI is one of the COVID-19 complications with high prognostic significance. In our research, we studied the prognostic role of several biomarkers that could help us understand AKI pathogenesis in patients with COVID-19. Methods. We evaluated the medical data of 500 patients hospitalized with COVID-19 in Tareev Clinic from 5 October 2020 to 1 March 2022. The diagnosis of COVID-19 was confirmed with positive RNA PCR in nasopharyngeal swabs and/or typical radiological findings on CT scans. Kidney function was assessed in accordance with KDIGO criteria. In the selected 89 patients, we evaluated serum levels of angiopoetin-1, KIM-1, MAC, and neutrophil elastase 2 and their prognostic significance. Results. The incidence of AKI in our study was 38%. The main risk factors for kidney injury were male sex, cardiovascular diseases, and chronic kidney disease. High serum angiopoetin-1 levels and a decrease in blood lymphocyte count and fibrinogen level also increased the risk of AKI. Conclusions. AKI is an independent risk factor for death in patients with COVID-19. We propose the prognostic model of AKI development, which includes the combination of serum levels of angiopoetin-1 and KIM-1 on admission. Our model can help to prevent AKI development in patients with coronavirus disease.


  • Open Access

    Angiopoietin-1 as a marker of endothelial dysfunction and a risk factor for acute kidney injury in patients with COVID-19: retrospective cohort study

    by A. A. Schepalina, N. V. Chebotareva, L. A. Akulkina, M. Yu. Brovko, V. I. Sholomova, P. P. Potapov, D. S. Valiulina, S. V. Moiseev

    Recently, data have been published on the leading role of endothelial dysfunction in the development of severe COVID-19, including acute renal failure (AKI) and poor prognosis in this group of patients.Aim. To define the role of angiopoetin-1(Ang-1) as a marker of endothelial dysfunction in development of AKI in patients, hospitalized with COVID-19.Materials and methods. 76 patients with confirmed coronavirus infection were included in the study. AKI was diagnosed according to KDIGO 2012 criteria in 44 patients (group 1), 32 patients without sings of kidney disfunction were in group 2. Beside standard clinical and laboratory markers on admission we evaluated serum Ang-1 level with ELISA. We used regression analysis for AKI risk factors evaluation, we calculated odds ratio (OR) and 95% confidence intervals (CI). We used Cox regression for evaluation of risk of death.Results. The serum level of angiopoietin-1 was significantly higher in patients with COVID-19 with AKI: 1.8 (1.5; 2.1) ng/ml vs 1.58 (1.29; 1.7) ng/ml in group 2, р < 0.01. In deceased patients, the level of Ang-1 at admission was significantly higher than in patients who was discharged: 1.91 (1.71; 2.32) ng/ml vs 1.58 (1.34; 1.67) ng/ml, respectively, p = 0.0001. In unifactorial regression analysis we confirmed, that increase of serum Ang-1 level >1.66 ng/ml on admission is the risk factor for AKI development in patients with COVID-19 (OR 5.7, 95% CI 1.7–19.1, р < 0.01). In Cox regression development of AKI increased the absolute risk of death: Hazard ratio = 5.159 (95% CI 1.839–14.469), p = 0.002.Conclusion. The high serum level of Ang-1 in patients with COVID-19 at hospital admission is the marker of systemic endothelial dysfunction and the risk factor for AKI and poor prognosis.

  • Open Access

    Evolution of ideas about the risk of tyramine syndrome developing during therapy with irreversible non-selective monoamine oxidase inhibitors (to the 70th anniversary of the first use of this group of antidepressants)

    by D. S. Danilov, M. Yu. Brovko

    We describe the history of studying of the problem of tyramine syndrome during the treatment with antidepressants, irreversible non-selective monoamine oxidase inhibitors. Data on clinical observations are presented. Early hypotheses of pathogenesis are considered. The period of discovery of the relationship between increased blood pressure and the use of foods containing tyramine is outlined. The transformation of terminology is demonstrated. The events associated with the restriction of the use of therapy are characterized. The formation of the opinion about the exaggeration of the risk of developing tyramine syndrome is analyzed. Data on the involvement in the discussion of the problem of tyramine syndrome of society as a whole are given.


  • Open Access

    A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease

    by L. A. Akulkina, M. Yu. Brovko, A. A. Schepalina, V. I. Sholomova, A. A. Kitbalian, A. S. Moiseev, P. P. Potapov, S. V. Moiseev

    Interstitial lung diseases (ILDs) is a wide group of diffuse parenchymal lung diseases that can lead to interstitial pulmonary fibrosis. Clinical course of all ILDs, in particular with chronic fibrosing phenotype, can be complicated by an acute exacerbation caused by infection. Today, data about clinical course of COVID-19 in patients with progressive interstitial lung diseases is limited. In this case we described the course of COVID-19 infection in a patient with an interstitial pneumonia with autoimmune features (IPAF) and a progressive pulmonary fibrosis (PPF). We also discussed the typical features of COVID-19 in this population and the directions for further research.